Atovaquone Molecular Chemical Structure (Mepron Spl Graphic 01)
Mepron Suspension
Product Images NDC 0173-0665
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mepron (NDC 0173-0665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Mepron 750 mg Bottle Label (Mepron Spl Graphic 02)
This text is the prescribing information for the medication "Mepron" containing Atovaquone 750mg/5mL in a 210mL suspension. It advises on storage conditions, dispensing requirements, and instructs to shake the medication gently before using. The medication is distributed by GlaxoSmithKline and made in Canada. The text also includes a National Drug Code (NDC) number and revision number for the prescribing information.*
Mepron 750 mg Per 5 mL, 42 Sachet Carton (Mepron Spl Graphic 03)
MEPRON is an oral suspension medication with the National Drug Code (NDC) 0173-0547-00. Each 5-mL sachet of MEPRON contains 750 mg of atovaquone, and the medication comes in a package with 42 sachets of 5 mL each. It must be stored within the temperature range of 15°C to 25°C (59°F to 77°F) and should not be frozen. The prescription is available only upon the recommendation of a healthcare professional, and appropriate dosage and administration guidelines can be found in the accompanying prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
